These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Fisniku LK; Brex PA; Altmann DR; Miszkiel KA; Benton CE; Lanyon R; Thompson AJ; Miller DH Brain; 2008 Mar; 131(Pt 3):808-17. PubMed ID: 18234696 [TBL] [Abstract][Full Text] [Related]
29. Heterogeneity of Multiple Sclerosis White Matter Lesions Detected With T2*-Weighted Imaging at 7.0 Tesla. Yao B; Ikonomidou VN; Cantor FK; Ohayon JM; Duyn J; Bagnato F J Neuroimaging; 2015; 25(5):799-806. PubMed ID: 25657078 [TBL] [Abstract][Full Text] [Related]
30. Susceptibility-weighted imaging helps to discriminate pediatric multiple sclerosis from acute disseminated encephalomyelitis. Kelly JE; Mar S; D'Angelo G; Zhou G; Rajderkar D; Benzinger TL Pediatr Neurol; 2015 Jan; 52(1):36-41. PubMed ID: 25532777 [TBL] [Abstract][Full Text] [Related]
31. T2 Relaxometry Evidence of Microstructural Changes in Diffusely Abnormal White Matter in Relapsing-Remitting Multiple Sclerosis and Clinically Isolated Syndrome: Impact on Visuomotor Performance. Papadaki E; Mastorodemos V; Panou T; Pouli S; Spyridaki E; Kavroulakis E; Kalaitzakis G; Maris TG; Simos P J Magn Reson Imaging; 2021 Oct; 54(4):1077-1087. PubMed ID: 33960066 [TBL] [Abstract][Full Text] [Related]
32. Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images. Hiehle JF; Grossman RI; Ramer KN; Gonzalez-Scarano F; Cohen JA AJNR Am J Neuroradiol; 1995 Jan; 16(1):69-77. PubMed ID: 7900604 [TBL] [Abstract][Full Text] [Related]
33. Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center. Kilic AK; Kurne AT; Oguz KK; Soylemezoglu F; Karabudak R Turk Neurosurg; 2013; 23(6):728-35. PubMed ID: 24310455 [TBL] [Abstract][Full Text] [Related]
34. Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations. Brex PA; Parker GJ; Leary SM; Molyneux PD; Barker GJ; Davie CA; Thompson AJ; Miller DH J Neurol Neurosurg Psychiatry; 2000 May; 68(5):627-32. PubMed ID: 10766895 [TBL] [Abstract][Full Text] [Related]
35. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. Rovaris M; Agosta F; Sormani MP; Inglese M; Martinelli V; Comi G; Filippi M Brain; 2003 Oct; 126(Pt 10):2323-32. PubMed ID: 12937086 [TBL] [Abstract][Full Text] [Related]
36. Longitudinal ultra-high field MRI of brain lesions in neuromyelitis optica spectrum disorders. Chawla S; Ge Y; Wuerfel J; Asadollahi S; Mohan S; Paul F; Sinnecker T; Kister I Mult Scler Relat Disord; 2020 Jul; 42():102066. PubMed ID: 32272444 [TBL] [Abstract][Full Text] [Related]
37. [Diagnostic imaging of hemangiomas in the brain]. Toyoda K; Oba H Brain Nerve; 2011 Jan; 63(1):5-15. PubMed ID: 21228443 [TBL] [Abstract][Full Text] [Related]
38. Consistency of the "central vein sign" in chronic multiple sclerosis lesions. Reichl M; Wittayer M; Weber CE; Platten M; Gass A; Eisele P Mult Scler Relat Disord; 2022 Feb; 58():103530. PubMed ID: 35066270 [TBL] [Abstract][Full Text] [Related]
39. Diffusivity in multiple sclerosis lesions: At the cutting edge? Klistorner A; Wang C; Fofanova V; Barnett MH; Yiannikas C; Parratt J; You Y; Graham SL Neuroimage Clin; 2016; 12():219-26. PubMed ID: 27489769 [TBL] [Abstract][Full Text] [Related]